1. Short communication for targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches- part 2
   Shailima Rampogu et al, 2020, Computational Biology and Chemistry CrossRef
2. Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells
   Aheli Majumder et al, 2019, Molecular and Cellular Biochemistry CrossRef
3. Modeling Neoadjuvant chemotherapy resistance in vitro increased NRP‐1 and HER2 expression and converted MCF7 breast cancer subtype
   Noura Al‐Zeheimi et al, 2020, British Journal of Pharmacology CrossRef
4. Maldevelopment of the submandibular gland in a mouse model of apert syndrome
   Kojiro Yamaji et al, 2018, Developmental Dynamics CrossRef
5. Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
   Aswathy R. Devan et al, 2021, Pharmaceuticals CrossRef
6. Afatinib Decreases P‐Glycoprotein Expression to Promote Adriamycin Toxicity of A549T Cells
   Yan Zhang et al, 2018, Journal of Cellular Biochemistry CrossRef
7. Blood cadmium levels associated with short distant metastasis-free survival time in invasive breast cancer
   Yuanfang He et al, 2017, Environmental Science and Pollution Research CrossRef
8. Enhanced antitumor effect of doxorubicin through active-targeted nanoparticles in doxorubicin-resistant triple-negative breast cancer
   Chi-Huang Hsiao et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
9. Long Noncoding RNAs in Taxane Resistance of Breast Cancer
   Hailong Chen et al, 2023, International Journal of Molecular Sciences CrossRef
10. Hyaluronic acid-modified cationic nanoparticles overcome enzyme CYP1B1-mediated breast cancer multidrug resistance
    Jun Zhang et al, 2019, Nanomedicine CrossRef
11. ABC transporters in breast cancer: their roles in multidrug resistance and beyond
    Anupama Modi et al, 2022, Journal of Drug Targeting CrossRef
12. Synthesis and biological evaluation of new series of quinazoline derivatives as EGFR/HER2 dual-target inhibitors
    Xiaoyu Jiao et al, 2022, Bioorganic & Medicinal Chemistry Letters CrossRef
13. Therapies to Overcome Multidrug-Resistant Receptors
    Noura Al-Zeheimi et al, 2019, Current Applications for Overcoming Resistance to Targeted Therapies CrossRef
14. Evaluation of the Synergistic Effect of the Combination of Doxorubicin and Vorinostat on Breast Tumor Cells Using the Loewe Model
    М. R. Mollaeva et al, 2023, Antibiotics and Chemotherapy CrossRef